KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $37.9 million.

  • Co-Diagnostics' Shares Outstanding (Weighted Average) rose 2425.61% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year increase of 2425.61%. This contributed to the annual value of $30.3 million for FY2024, which is 336.92% up from last year.
  • Per Co-Diagnostics' latest filing, its Shares Outstanding (Weighted Average) stood at $37.9 million for Q3 2025, which was up 2425.61% from $33.1 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Shares Outstanding (Weighted Average) registered a high of $37.9 million during Q3 2025, and its lowest value of $28.7 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $30.9 million, with a median of $30.1 million in 2024.
  • As far as peak fluctuations go, Co-Diagnostics' Shares Outstanding (Weighted Average) surged by 2560.18% in 2021, and later plummeted by 1311.91% in 2023.
  • Co-Diagnostics' Shares Outstanding (Weighted Average) (Quarter) stood at $28.9 million in 2021, then grew by 9.02% to $31.5 million in 2022, then fell by 6.77% to $29.3 million in 2023, then rose by 3.37% to $30.3 million in 2024, then grew by 24.91% to $37.9 million in 2025.
  • Its last three reported values are $37.9 million in Q3 2025, $33.1 million for Q2 2025, and $32.0 million during Q1 2025.